These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37755242)

  • 1. Gabapentin-Associated Movement Disorders: A Literature Review.
    Rissardo JP; Medeiros Araujo de Matos U; Fornari Caprara AL
    Medicines (Basel); 2023 Sep; 10(9):. PubMed ID: 37755242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin-associated movement disorders: A literature review.
    Rissardo JP; Caprara ALF
    Brain Circ; 2020; 6(2):96-106. PubMed ID: 33033779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF
    Clin Neuropharmacol; 2020; 43(3):66-80. PubMed ID: 32384309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium-associated movement disorder: A literature review.
    Rissardo JP; Caprara ALF; Durante Í; Rauber A
    Brain Circ; 2022; 8(2):76-86. PubMed ID: 35909709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone-Associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF
    Medicines (Basel); 2023 May; 10(6):. PubMed ID: 37367728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone-associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF
    Prague Med Rep; 2020; 121(1):5-24. PubMed ID: 32191616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF; Durante Í
    Prague Med Rep; 2021; 122(3):140-180. PubMed ID: 34606429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine-Associated Movement Disorder: A Literature Review.
    Rissardo JP; Fornari Caprara AL
    Neurol India; 2021; 69(6):1524-1538. PubMed ID: 34979637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocysticercosis and movement disorders: A literature review.
    Rissardo JP; Caprara ALF; Durante Í
    Brain Circ; 2020; 6(4):225-241. PubMed ID: 33506145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin-associated movement disorder: A literature review.
    Rissardo JP; Caprara ALF
    Tzu Chi Med J; 2022; 34(4):409-417. PubMed ID: 36578637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Link Between Amitriptyline and Movement Disorders: Clinical Profile and Outcome.
    Rissardo JP; Caprara ALF
    Ann Acad Med Singap; 2020 Apr; 49(4):236-251. PubMed ID: 32419008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine-associated movement disorders: A literature review.
    Rissardo JP; Caprara ALF
    Tzu Chi Med J; 2020; 32(4):318-330. PubMed ID: 33163376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin or pregabalin induced myoclonus: A case series and literature review.
    Desai A; Kherallah Y; Szabo C; Marawar R
    J Clin Neurosci; 2019 Mar; 61():225-234. PubMed ID: 30381161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement disorders associated with the use of gabapentin.
    Reeves AL; So EL; Sharbrough FW; Krahn LE
    Epilepsia; 1996 Oct; 37(10):988-90. PubMed ID: 8822698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin-induced myoclonus in end-stage renal disease.
    Zhang C; Glenn DG; Bell WL; O'Donovan CA
    Epilepsia; 2005 Jan; 46(1):156-8. PubMed ID: 15660783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoclonus induced by the use of gabapentin.
    Cho KT; Hong SK
    J Korean Neurosurg Soc; 2008 May; 43(5):237-8. PubMed ID: 19096603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.